Cipla
CIPLA
Cipla Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | 7.35% | 25,27,204 |
| Weekly | 7.94% | 60,29,239 |
| Monthly | 8.14% | 1,95,61,152 |
Cipla Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| CIPLA | 7.35% | 7.94% | 8.14% |
| Index | - | - | - |
| Peer Avg. | 1.75% | 5.43% | 11.19% |
Cipla Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| CIPLA | 31.60 | 3.80 | 17.73 | 12.90 | 17.04 | 0.47 |
| Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
| Peer Avg. | 39.55 | 4.75 | 12.35 | 13.59 | 17.02 | 0.87 |
Cipla Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | 14.71% | 19.06% | 12.90% | 17.04% |
| FY '20-21 | 0.56% | 21.71% | 12.55% | 16.50% |
| FY '19-20 | 3.50% | 12.62% | 12.05% | 15.31% |
Cipla Shareholding Pattern
Cipla Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 17,427.56 | 13,488.35 | 4,433.43 | 2,624.43 |
| FY '20-21 | 15,231.15 | 11,573.12 | 3,908.05 | 2,222.97 |
| FY '19-20 | 14,895.57 | 11,961.98 | 3,575.16 | 1,932.58 |
Cipla Peer Comparison
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| CIPLA | 17,427.56 | 13,488.35 | 4,433.43 | 2,624.43 |
| TORNTPHARM | 7,625.18 | 5,359.17 | 2,466.38 | 884.32 |
| DIVISLAB | 8,919.83 | 5,041.89 | 3,992.91 | 2,954.49 |
Cipla Share Price
Cipla Limited is an Indian company primarily engaged in the pharmaceutical business. The company's segments are Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and markets generic or branded generic drugs and active ingredients (APIs). The New Ventures segment includes corporate operations, consumer healthcare, biosimilar and specialty businesses. Its product portfolio includes complex generics and respiratory, antiretroviral, urology, cardiology, infectious and CNS medicines and CNS and CNS medicines. The company's geographic segments include India, the United States, South Africa and the rest of the world. The company has a network of manufacturing, trading and other incidental activities in India and international markets. The company has about 46 factories.